In this paper, we will review recent literature on the expression, dynamic, and relevance of Glut1 in T cells to evaluate the potential therapeutic value of pharmacological Glut1 blockade for T1D. The gene discussed is SLC2A1; the disease is type 1 diabetes mellitus.